Activation of GRP78 on endothelial cell membranes by an ADAM15-derived peptide induces angiogenesis

Journal of Vascular Research

Volumn 47, Issue 5, 2010, Pages 399-411

  Raiter, Annat ^a   Weiss, Chana ^a   Bechor, Zafrir ^a   Ben Dor, Itzik ^b   Battler, Alexander ^b   Kaplan, Boris ^c   Hardy, Britta ^a  

^a TEL AVIV UNIVERSITY   (Israel)

^b Department of Cardiology ^*  (Ireland)

^c Rabin Medical Center   (Ireland)

Author keywords

Angiogenesis; Endothelial cells; Heat shock GRP78 protein; HWRR motif; Ischemia model

Indexed keywords

ADAM PROTEIN; ADAM15 PROTEIN; GLUCOSE REGULATED PROTEIN 78; HISTIDINYLTRYPTOPHANYLARGINYLARGININE; MESSENGER RNA; METALLOPROTEINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PEPTIDE; PROTEIN KINASE B; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; VASCULOTROPIN;

AMINO ACID SEQUENCE; ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL MEMBRANE; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HYPOXIA; ISCHEMIA; LIMB ISCHEMIA; MOUSE; NONHUMAN; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DATABASE; TISSUE PERFUSION; WESTERN BLOTTING;

ADAM PROTEINS; ANIMALS; CELLS, CULTURED; ENDOTHELIAL CELLS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HEAT-SHOCK PROTEINS; HINDLIMB; HUMANS; ISCHEMIA; MEMBRANE PROTEINS; MICE; MITOGEN-ACTIVATED PROTEIN KINASE 3; NEOVASCULARIZATION, PHYSIOLOGIC; OLIGOPEPTIDES; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 76049112584     PISSN: 10181172     EISSN: None     Source Type: Journal    
DOI: 10.1159/000281580     Document Type: Article

References (27)

1. Glienke J, Schmitt AO, Pilarsky C, Hinzmann B, Weiss B, Rosenthal A, Thierauch KH: Differential gene expression by endothelial cells in distinct angiogenic states. Eur J Biochem 2000; 267:2820-2830.
2. Ahn A, Frishman WH, Gutwein A, Passeri J, Nelson M: Therapeutic angiogenesis: a new treatment approach for ischemic heart disease. Part II. Cardiol Rev 2009; 16: 219-229.
3. Hardy B, Raiter A, Weiss C, Kaplan B, Te-nenbaum A, Battler A: Angiogenesis induced by novel peptides selected from a phage display library by screening human vascular en-dothelial cells under different physiological conditions. Peptides 2007; 28:691-701.
4. Hardy B, Bat t ler A, Wei ss C, Kudasi O, R a i ter A: Therapeutic angiogenesis of mouse hind limb ischemia by novel peptide activating GRP78 receptor on endothelial cells. Bio-chem Pharm 20 08; 75: 891-899.
5. Fourie AM, Coles F, Moreno V, Karlsson L: Catalytic activity of ADAM8, ADAM15, and MDC-L (ADAM28) on synthetic peptide substrates and in ectodomain cleavage of CD23. J Biol Chem 2003; 278:30469-30477.
6. Horiuchi K, Weskamp G, Lum L, Hammes HP, Cai H, Brodie TA, Ludwig T, Chiusaroli R, Baron R, Preissner KT, Manova K, Blobel CP: Potential role for ADAM15 in pathological neovascularization in mice. Mol Cell Biol 2003; 23:5614-5624.
7. Koji Eto K, Huet C, Tarui T, Kupriyanov S, Liu HZ, Puzon-McLaughlin W, Zhang X P, Sheppard D, Engvall E, Takada Y: Functional classification of ADAMs based on a conserved motif for binding to integrin. J Biol Chem 2002; 277:17804-17810.
8. Trochon-Joseph V, Martel-Renoir D, Mir LM, Thoma?dis A, Connault E, Li H, Grenet C, Fauvel-Lafeve F, Soria J, Legrand C, Soria C, Perricaudet M, Lu H: Evidence of antian-giogenic and antimetastatic activities of the recombinant disintegrin domain of metargi-din. Can Res 2004; 6 4: 2062-20 69.
9. White J: ADAMs: modulators of cell-cell and cell-matrix interactions. Curr Opin Cell Biol 2003; 15:598-606.
10. Bohm BB, Aigner T, Roy B, Brodie TA, Blobel CP, Burkhardt H: Homeostatic effects of the metalloproteinase disintegrin ADAM15 in degenerative cartilage remodeling. Arthritis Rheum 2005; 2: 11 0 0-11 0 9.
11. Charrier-Hisamuddin L, Laboisse CL, Merlin D: ADAM-15: a metalloprotease that mediates inf lammation. FASEB J 2008; 22: 641-653.
12. Martin J, Eynstone LV, Davies M, Williams JD, Steadman R: The role of ADAM15 in glo-merular mesangial cell migration. J Biol Chem 2002; 27 7: 33683-33689.
13. Jaffe EA, Hoyer LW, Nachman RL: Synthesis of antihemophilic factor antigen by cultured human endothelial cells. J Clin Invest 1973; 52: 2757-2764.
14. Cao R, Brakenhielm E, Pawliuk R, Wrarjaro D, Post MJ, Wahlberg E: Angiogenic-syner-gism, vascular stability and improvement of hind-limb ischemia by a combination of PDGF-BB and FGF-2. Nat Med 2003; 9:604-613.
15. Sun Q, Chen RR, Shen Y, Mooney DJ, Raja-gopalan S, Grossman PM: Sustained vas cular endothelial growth factor delivery enhances angiogenesis and perfusion in ischemic hind limb. Pharm Res 2005; 22:110-1116.
16. Couffinhal T, Silver M, Zheng LP, Kearney M, Witzenbichler B, Isner JM: Mouse model of angiogenesis. Am J Pathol 1998; 152:1667-1679.
17. Inoue H, Lin L, Lee X, Shao Z, Mendes S, Snodgrass-Belt P, Sweigard H, Engber T, Pe-pinsky B, Yang L, Beal MF, Mi S, Isacson O: Inhibition of the leucine-rich repeat protein LINGO-1 enhances survival, structure, and function of dopaminergic neurons in Parkinson's disease models. Proc Natl Acad Sci USA 2007;104:14430-14435.
18. Koutroubakis IE, Tsiolakidou G, Karmiris K, Kouroumalis EA: Role of angiogenesis in inflammatory bowel disease. Inflamm Bowel Dis 2006; 12:515-523.
19. Shin JY, Kim JK, Kim B, Yun IH, Park CG: Expression of vascular endothelial growth factor receptor 1 (VEGFR-1), but not VEGFR-2 in activated lymphocytes and its function in response to VEGF. J Immunol 2007; 178:4928.
20. Stepanova OI, Krylov AV, Lioudyno VI, Kis-seleva EP: Gene expression for VEGF-A, VEGF-C, and their receptors in murine lymphocytes and macrophages. Biochemistry (Mosc) 2007; 72: 1194-1198.
21. Lee AS: GRP78 induction in cancer: therapeutic and prognostic implications. Can Res 2007; 67:3496-3499.
22. Misra UK, Deedwania R, Pizzo SV: Activation and cross talk between Akt, NF-KB, and unfolded protein response signaling in 1-LN prostate cancer cells consequent to ligation of cell surface-associated GRP78. J Biol Chem 2006; 281: 13694-13707.
23. 2M*- stimulated macrophages. J Cell Bio-chem 2008; 104:96-104.
24. Davidson DJ, Haskell C, Majest S, Kherzai A, Egan DA, Walter KA, Schneider A, Gubbins EF, Solomon L, Chen Z, Lesniewski R, Hen-kin J: Kringle 5 of human plasminogen induces apoptosis of endothelial and tumor cells through surface-expressed glucose-regulated protein 78. Can Res 2005; 65:4663-4672.
25. Reddy RK, Mao C, Baumeister P, Austin RC, Kaufman RJ, Lee AS: Endoplasmic reticu-lum chaperone protein GRP78 protects cells from apoptosis induced by topoisomerase inhibitors: role of ATP binding site in suppression of caspase-7 activation. J Biol Chem 2003; 278: 20915-20924.
26. Song MS, Park YK, Lee JH, Park K: Induction of glucose-regulated protein 78 by chronic hypoxia in human gastric tumor cells through a protein kinase C-epsilon/ERK/AP-1 signaling cascade. Can Res 2001; 61:8322-8330.
27. Li C, Issa R, Kumar P, Hampson IN, Lopez-Novoa JM, Bernabeu C, Kumar S: CD105 prevents apoptosis in hypoxic endothelial cells. J Cell Sci 2003; 116:2677-2685.